Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: (no name provided) who wrote (7505)	4/27/1998 4:50:00 PM
From: NicholasC	Respond to of 23519

Never said I thought that they were capacity constrained now. Aren't you groping for the downside. I do believe that there is room for MUSE in the market. I am most impressed, and looking to see, that Viagra sales are strong and expanding the market. -N

To: (no name provided) who wrote (7505)	4/27/1998 5:14:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Dear No name...,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Vivus was capacity constrained until Feb...shipping product to Astra to supply the UK from the old plant. In Feb the new plant was certified by the MCA...Sales in the last 4 1/2 weeks in the UK were $1.9 mill from Astra to Vivus.... The script data does not include what is going to the UK..and soon to Brazil,Argentina,S.Korea,Switzerland ... Wait for the annual meeting May 21st let's see if any additional countries are announced. Come back and review the script data in June,July and see how many people use Muse (come back to Muse or new customers that couldn't use Viagra or weren't happy with Viagra)...